How Yale's Phase I Program is Impacting Patient Care and Driving Oncology Advances
Yale Cancer Center via YouTube
Build AI Apps with Azure, Copilot, and Generative AI — Microsoft Certified
Start speaking a new language. It’s just 3 weeks away.
Overview
Google, IBM & Meta Certificates – 40% Off
One plan covers every Professional Certificate on Coursera.
Unlock All Certificates
Learn how Yale's Phase I clinical trial program is revolutionizing patient care and advancing oncology research through this 25-minute conference presentation from Yale Cancer Center's Review of Advances in Oncology from the 2025 ASCO Annual Meeting. Discover the innovative approaches and methodologies employed by Yale's Phase I program that are directly impacting patient outcomes and contributing to breakthrough developments in cancer treatment. Explore the intersection of cutting-edge clinical research and practical patient care applications, examining how early-phase clinical trials are being designed and implemented to maximize both scientific advancement and therapeutic benefit for patients. Gain insights into the program's unique strategies for patient selection, trial design, and translational research that are setting new standards in oncology clinical development. Understand the broader implications of Phase I research on the future of cancer treatment and how academic medical centers are leading the charge in transforming experimental therapies into viable treatment options for patients with cancer.
Syllabus
How Yale’s Phase I Program is Impacting Patient Care and Driving Oncology Advances
Taught by
Yale Cancer Center